Contractile 5-HT(1B) receptors in human cerebral arteries: Pharmacological characterization and localization with immunocytochemistry

British Journal of Pharmacology

Volumn 128, Issue 6, 1999, Pages 1133-1140

  Nilsson, Torun ^a   Longmore, Jenny ^b   Shaw, David ^b   Jansen Olesen, Inger ^c   Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

5 HT receptors; Endothelium; Immunocytochemistry; In vitro pharmacology; Smooth muscle

Indexed keywords

2 METHYLSEROTONIN; 3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; 5 CARBAMOYLTRYPTAMINE; ALPHA METHYLSEROTONIN; AVITRIPTAN; DIHYDROERGOTAMINE; KETANSERIN; NARATRIPTAN; PRAZOSIN; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1B RECEPTOR; SULPIRIDE; SUMATRIPTAN; ZOLMITRIPTAN; HTR1B PROTEIN, HUMAN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ARTICLE; BRAIN ARTERY; COMPETITIVE INHIBITION; DRUG INHIBITION; DRUG POTENCY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; BINDING COMPETITION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METABOLISM; PHYSIOLOGY;

BINDING, COMPETITIVE; CEREBRAL ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; VASOCONSTRICTION;

EID: 0033219853     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702773     Document Type: Article

References (40)

1. BOUCHELET, I., COHEN, Z., BRUCE, C., SEGUELA, P. & HAMEL, E. (1996). Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol. Pharmacol., 60, 219-223.
2. 1B, 1D receptors mediating the anti-migraine effect of Sumatriptan and dihydroergotamine. Cephalalgia, 11, 165-168.
3. CONNOR, H.E. & BEATTIE, D.T. (1996). 5-Hydroxytryptamine receptor subtypes and migraine. In: Migraine: Pharmacology and Genetics. Sandler M, Ferrari M & Harnett S, eds pp 18-27 London, Chapman and Hall.
4. CONNOR, H.E., FENIUK, W., BEATTIE, D.T., NORTH, P.C., OXFORD, A.W., SAYNOR, D.A. & HUMPHFREY, P.P.A. (1997). Naratriptan: biological profile in animal models relevant to migraine. Cephalalgia, 17, 145-152.
5. 1Dα) encoded by an intronless gene on chromosome 6. Proc. Natl. Acad. Sci. U.S.A., 89, 5522-5526.
6. 1B 1D-receptor ligand. Br. J. Pharmacol. Proc. Suppl., (in press).
7. EDVINSSON, L., HARDEBO, J.E. & OWMAN, C. (1978). Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man. Circ. Res., 42, 143-151.
8. 1 receptors in migraine pathophysiology and treatment. Eur. J. Neurol., 2, 5-21.
9. FRIBERG, L., OLESEN, J., IVERSFN, H.K. & SPERLING, B. (1991). Migraine pain associated with middle cerebral artery dilation: reversal by sumatriptan. Lancet. 338, 13-17.
10. 1D -type serotonin receptor. Mol. Pharmacol., 40, 143-148.
11. 1D binding sites. Br. J. Pharmacol., 102, 227-233.
12. 1D receptor subtype in human and bovine cerebral arteries. Mol. Pharmacol., 44, 242-246.
13. 1D receptor genes. Trends Pharmacol. Sci., 13, 152-159.
14. HÖGESTÄTT, E.D., ANDERSSON, K-E. & EDVINSSON, L. (1983). Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol. Scand., 1771, 49-61.
15. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). VII International Union of Pharmacology Classification of Receptors for 5-Hydroxytryptamine (Serotonin). Pharmacol. Rev., 46, 157-203.
16. HUMPHREY, P.P.A. & FENIUK, W. (1991). Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol. Sci., 12, 444-446.
17. HUMPHREY, P.P.A , FENIUK, W., PERREN, M.J., CONNOR, H.F., OXFORD, A.W., COATIS, I.H. & BUTINA, D. (1988). GR 43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol., 94, 1123-1132.
18. JANSEN, I., EDVINSSON, L., MORTENSEN, A. & OLESEN, J. (1992). Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Cephalalgia, 12, 202-205.
19. JANSEN, I., OLESEN, J. & EDVINSSON, L. (1993). 5-Hydroxytryptamine receptor characterisation of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol. Scand., 147, 141-150.
20. 1B receptor. J. Biol. Chem., 267, 5735-5738.
21. 1P receptor agonists inhibit neurogenic dural inflammation in guinea pigs. Neuroreport, 8, 2237-2240.
22. 1Dβ receptor. Circulation, 90, 1141-1153.
23. 1D subtype. J. Biol. Chem., 267, 7553-7562.
24. 1B-receptors. Br. J. Clin. Pharmacol., 46, 577-582.
25. 1D immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia, 17, 833-842.
26. 1B, 1D receptor partial agonist, 311C90 (zolmitriptan). Br. J. Pharmacol., 121, 157-164.
27. MAY, A. BAHRA, A., BÜCHEL, C., FRACKOWIAK, R.S.J. & GOADSBY, P.J. (1998). Hypothalamic activation in cluster headache attacks. Lancet, 352, 275-278.
28. - receptors. Nature (Lond.), 360, 161-163.
29. 1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br. J. Pharmacol., 96, 434-449.
30. 1D binding sites. Eur. J. Pharmacol., 163, 133-136.
31. PERREN, M.J., FENIUK, W. & HUMPHREY, P.P.A. (1989). The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175. Cephalalgia, 9 (Suppl 9). 41-46.
32. 1F receptor activation. Br. J. Clin. Pharmacol., 47, 75-82.
33. 1Dα serotonin receptor gene expression in trigeminal ganglia: Implications for antimigraine drug development. Proc. Natl. Acad. Sci., U.S.A., 91, 3666-3669.
34. 1B antimigraine drug receptor in rat and human brain microvessels. Neuroscience, 86, 1031-1035.
35. 2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci. 25, 637-654.
36. VAN ES, N.M., BRUNING, T.A., CAMPS, J., CHANG, P.C., BLAUW, G.J., FERRARI, M.D., SAXENA, P.R. & VAN ZWIETEN, P.A. (1995). Assessment of peripheral vascular effects of antimigraine drugs in humans. Cephalalgia, 15, 288-291.
37. 2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs. Br. J. Pharmacol., 117, 283-292.
38. 1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression. Br. J. Pharmacol., 124, 1345-1354.
39. WEILLER, C., MAY, A., LIMMROTH, V., JÜPTNER, M., KAUBE, H., SCHAYCK, R.V., COENEN, H.H. & DIENER, H.C. (1995). Brain stem activation in spontaneous human migraine attacks. Nat. Med., 1, 658-660.
40. 1Dβ. Proc. Natl. Acad. Sci. U.S.A., 89, 3630-3634.